ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transdermal Drug Delivery(TDD) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-37H16520
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Transdermal Drug Delivery TDD Market Research Report 2024
BUY CHAPTERS

Global Transdermal Drug Delivery(TDD) Market Research Report 2025

Code: QYRE-Auto-37H16520
Report
September 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hisamitsu
Mylan NV
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
TEIKOKU SEIYAKU
Bayer
Lingrui
Sanofi
Zhejiang Ausun Pharmaceutical
Endo International
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
ProStrakan
Allergan plc

Transdermal Drug Delivery(TDD) Market

The global market for Transdermal Drug Delivery(TDD) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Transdermal therapeutic system (TTS or transdermal delivery system, TDS) or transdermal absorption preparation refers to the use of pharmaceutical, physical and chemical methods to promote the penetration of drugs at a constant rate (or close to a constant rate). It is a new dosage form that enters the circulatory system through the skin surface and produces systemic or local therapeutic effects. In a narrow sense, transdermal drug delivery forms are patches or patches; in a broad sense, TDS includes not only patches (tablets), but also ointments, plasters, liniments and aerosols, as well as non-innovative agents such as traditional patches. .
North American market for Transdermal Drug Delivery(TDD) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transdermal Drug Delivery(TDD) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Transdermal Drug Delivery(TDD) include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery(TDD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery(TDD).
The Transdermal Drug Delivery(TDD) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Drug Delivery(TDD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Delivery(TDD) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Transdermal Drug Delivery(TDD) Market Report

Report Metric Details
Report Name Transdermal Drug Delivery(TDD) Market
Segment by Type
  • Topical Application
  • Systemic Administration
Segment by Application
  • Prescription
  • Non-prescription Drugs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Zhejiang Ausun Pharmaceutical, Endo International), Huarun 999, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier, ProStrakan, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Transdermal Drug Delivery(TDD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Transdermal Drug Delivery(TDD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Transdermal Drug Delivery(TDD) Market report?

Ans: The main players in the Transdermal Drug Delivery(TDD) Market are Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Zhejiang Ausun Pharmaceutical, Endo International), Huarun 999, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier, ProStrakan, Allergan

What are the Application segmentation covered in the Transdermal Drug Delivery(TDD) Market report?

Ans: The Applications covered in the Transdermal Drug Delivery(TDD) Market report are Prescription, Non-prescription Drugs

What are the Type segmentation covered in the Transdermal Drug Delivery(TDD) Market report?

Ans: The Types covered in the Transdermal Drug Delivery(TDD) Market report are Topical Application, Systemic Administration

1 Transdermal Drug Delivery(TDD) Market Overview
1.1 Product Definition
1.2 Transdermal Drug Delivery(TDD) by Type
1.2.1 Global Transdermal Drug Delivery(TDD) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Topical Application
1.2.3 Systemic Administration
1.3 Transdermal Drug Delivery(TDD) by Application
1.3.1 Global Transdermal Drug Delivery(TDD) Market Value by Application (2024 VS 2031)
1.3.2 Prescription
1.3.3 Non-prescription Drugs
1.4 Global Transdermal Drug Delivery(TDD) Market Size Estimates and Forecasts
1.4.1 Global Transdermal Drug Delivery(TDD) Revenue 2020-2031
1.4.2 Global Transdermal Drug Delivery(TDD) Sales 2020-2031
1.4.3 Global Transdermal Drug Delivery(TDD) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transdermal Drug Delivery(TDD) Market Competition by Manufacturers
2.1 Global Transdermal Drug Delivery(TDD) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transdermal Drug Delivery(TDD) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transdermal Drug Delivery(TDD) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transdermal Drug Delivery(TDD), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Drug Delivery(TDD), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Drug Delivery(TDD), Product Type & Application
2.7 Global Key Manufacturers of Transdermal Drug Delivery(TDD), Date of Enter into This Industry
2.8 Global Transdermal Drug Delivery(TDD) Market Competitive Situation and Trends
2.8.1 Global Transdermal Drug Delivery(TDD) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transdermal Drug Delivery(TDD) Players Market Share by Revenue
2.8.3 Global Transdermal Drug Delivery(TDD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transdermal Drug Delivery(TDD) Market Scenario by Region
3.1 Global Transdermal Drug Delivery(TDD) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transdermal Drug Delivery(TDD) Sales by Region: 2020-2031
3.2.1 Global Transdermal Drug Delivery(TDD) Sales by Region: 2020-2025
3.2.2 Global Transdermal Drug Delivery(TDD) Sales by Region: 2026-2031
3.3 Global Transdermal Drug Delivery(TDD) Revenue by Region: 2020-2031
3.3.1 Global Transdermal Drug Delivery(TDD) Revenue by Region: 2020-2025
3.3.2 Global Transdermal Drug Delivery(TDD) Revenue by Region: 2026-2031
3.4 North America Transdermal Drug Delivery(TDD) Market Facts & Figures by Country
3.4.1 North America Transdermal Drug Delivery(TDD) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transdermal Drug Delivery(TDD) Sales by Country (2020-2031)
3.4.3 North America Transdermal Drug Delivery(TDD) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transdermal Drug Delivery(TDD) Market Facts & Figures by Country
3.5.1 Europe Transdermal Drug Delivery(TDD) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transdermal Drug Delivery(TDD) Sales by Country (2020-2031)
3.5.3 Europe Transdermal Drug Delivery(TDD) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Drug Delivery(TDD) Market Facts & Figures by Region
3.6.1 Asia Pacific Transdermal Drug Delivery(TDD) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transdermal Drug Delivery(TDD) Sales by Region (2020-2031)
3.6.3 Asia Pacific Transdermal Drug Delivery(TDD) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Transdermal Drug Delivery(TDD) Market Facts & Figures by Country
3.7.1 Latin America Transdermal Drug Delivery(TDD) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transdermal Drug Delivery(TDD) Sales by Country (2020-2031)
3.7.3 Latin America Transdermal Drug Delivery(TDD) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Drug Delivery(TDD) Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Drug Delivery(TDD) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transdermal Drug Delivery(TDD) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transdermal Drug Delivery(TDD) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Drug Delivery(TDD) Sales by Type (2020-2031)
4.1.1 Global Transdermal Drug Delivery(TDD) Sales by Type (2020-2025)
4.1.2 Global Transdermal Drug Delivery(TDD) Sales by Type (2026-2031)
4.1.3 Global Transdermal Drug Delivery(TDD) Sales Market Share by Type (2020-2031)
4.2 Global Transdermal Drug Delivery(TDD) Revenue by Type (2020-2031)
4.2.1 Global Transdermal Drug Delivery(TDD) Revenue by Type (2020-2025)
4.2.2 Global Transdermal Drug Delivery(TDD) Revenue by Type (2026-2031)
4.2.3 Global Transdermal Drug Delivery(TDD) Revenue Market Share by Type (2020-2031)
4.3 Global Transdermal Drug Delivery(TDD) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transdermal Drug Delivery(TDD) Sales by Application (2020-2031)
5.1.1 Global Transdermal Drug Delivery(TDD) Sales by Application (2020-2025)
5.1.2 Global Transdermal Drug Delivery(TDD) Sales by Application (2026-2031)
5.1.3 Global Transdermal Drug Delivery(TDD) Sales Market Share by Application (2020-2031)
5.2 Global Transdermal Drug Delivery(TDD) Revenue by Application (2020-2031)
5.2.1 Global Transdermal Drug Delivery(TDD) Revenue by Application (2020-2025)
5.2.2 Global Transdermal Drug Delivery(TDD) Revenue by Application (2026-2031)
5.2.3 Global Transdermal Drug Delivery(TDD) Revenue Market Share by Application (2020-2031)
5.3 Global Transdermal Drug Delivery(TDD) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu
6.1.1 Hisamitsu Company Information
6.1.2 Hisamitsu Description and Business Overview
6.1.3 Hisamitsu Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Transdermal Drug Delivery(TDD) Product Portfolio
6.1.5 Hisamitsu Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Transdermal Drug Delivery(TDD) Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Transdermal Drug Delivery(TDD) Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Transdermal Drug Delivery(TDD) Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Teve (Actavis)
6.5.1 Teve (Actavis) Company Information
6.5.2 Teve (Actavis) Description and Business Overview
6.5.3 Teve (Actavis) Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teve (Actavis) Transdermal Drug Delivery(TDD) Product Portfolio
6.5.5 Teve (Actavis) Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Transdermal Drug Delivery(TDD) Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Lohmann
6.7.1 Lohmann Company Information
6.7.2 Lohmann Description and Business Overview
6.7.3 Lohmann Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lohmann Transdermal Drug Delivery(TDD) Product Portfolio
6.7.5 Lohmann Recent Developments/Updates
6.8 Teikoku Seiyaku
6.8.1 Teikoku Seiyaku Company Information
6.8.2 Teikoku Seiyaku Description and Business Overview
6.8.3 Teikoku Seiyaku Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teikoku Seiyaku Transdermal Drug Delivery(TDD) Product Portfolio
6.8.5 Teikoku Seiyaku Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Transdermal Drug Delivery(TDD) Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Lingrui
6.10.1 Lingrui Company Information
6.10.2 Lingrui Description and Business Overview
6.10.3 Lingrui Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lingrui Transdermal Drug Delivery(TDD) Product Portfolio
6.10.5 Lingrui Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Company Information
6.11.2 Sanofi Description and Business Overview
6.11.3 Sanofi Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi Transdermal Drug Delivery(TDD) Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Zhejiang Ausun Pharmaceutical
6.12.1 Zhejiang Ausun Pharmaceutical Company Information
6.12.2 Zhejiang Ausun Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Ausun Pharmaceutical Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Ausun Pharmaceutical Transdermal Drug Delivery(TDD) Product Portfolio
6.12.5 Zhejiang Ausun Pharmaceutical Recent Developments/Updates
6.13 Endo International)
6.13.1 Endo International) Company Information
6.13.2 Endo International) Description and Business Overview
6.13.3 Endo International) Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Endo International) Transdermal Drug Delivery(TDD) Product Portfolio
6.13.5 Endo International) Recent Developments/Updates
6.14 Huarun 999
6.14.1 Huarun 999 Company Information
6.14.2 Huarun 999 Description and Business Overview
6.14.3 Huarun 999 Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Huarun 999 Transdermal Drug Delivery(TDD) Product Portfolio
6.14.5 Huarun 999 Recent Developments/Updates
6.15 Haw Par
6.15.1 Haw Par Company Information
6.15.2 Haw Par Description and Business Overview
6.15.3 Haw Par Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Haw Par Transdermal Drug Delivery(TDD) Product Portfolio
6.15.5 Haw Par Recent Developments/Updates
6.16 Nichiban
6.16.1 Nichiban Company Information
6.16.2 Nichiban Description and Business Overview
6.16.3 Nichiban Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Nichiban Transdermal Drug Delivery(TDD) Product Portfolio
6.16.5 Nichiban Recent Developments/Updates
6.17 Mentholatum
6.17.1 Mentholatum Company Information
6.17.2 Mentholatum Description and Business Overview
6.17.3 Mentholatum Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Mentholatum Transdermal Drug Delivery(TDD) Product Portfolio
6.17.5 Mentholatum Recent Developments/Updates
6.18 Laboratoires Genevrier
6.18.1 Laboratoires Genevrier Company Information
6.18.2 Laboratoires Genevrier Description and Business Overview
6.18.3 Laboratoires Genevrier Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Laboratoires Genevrier Transdermal Drug Delivery(TDD) Product Portfolio
6.18.5 Laboratoires Genevrier Recent Developments/Updates
6.19 ProStrakan
6.19.1 ProStrakan Company Information
6.19.2 ProStrakan Description and Business Overview
6.19.3 ProStrakan Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.19.4 ProStrakan Transdermal Drug Delivery(TDD) Product Portfolio
6.19.5 ProStrakan Recent Developments/Updates
6.20 Allergan
6.20.1 Allergan Company Information
6.20.2 Allergan Description and Business Overview
6.20.3 Allergan Transdermal Drug Delivery(TDD) Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Allergan Transdermal Drug Delivery(TDD) Product Portfolio
6.20.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Drug Delivery(TDD) Industry Chain Analysis
7.2 Transdermal Drug Delivery(TDD) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Drug Delivery(TDD) Production Mode & Process Analysis
7.4 Transdermal Drug Delivery(TDD) Sales and Marketing
7.4.1 Transdermal Drug Delivery(TDD) Sales Channels
7.4.2 Transdermal Drug Delivery(TDD) Distributors
7.5 Transdermal Drug Delivery(TDD) Customer Analysis
8 Transdermal Drug Delivery(TDD) Market Dynamics
8.1 Transdermal Drug Delivery(TDD) Industry Trends
8.2 Transdermal Drug Delivery(TDD) Market Drivers
8.3 Transdermal Drug Delivery(TDD) Market Challenges
8.4 Transdermal Drug Delivery(TDD) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Hisamitsu
Mylan NV
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
TEIKOKU SEIYAKU
Bayer
Lingrui
Sanofi
Zhejiang Ausun Pharmaceutical
Endo International
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
ProStrakan
Allergan plc
List of Tables
 Table 1. Global Transdermal Drug Delivery(TDD) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Transdermal Drug Delivery(TDD) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Transdermal Drug Delivery(TDD) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Transdermal Drug Delivery(TDD) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Transdermal Drug Delivery(TDD) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Transdermal Drug Delivery(TDD) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Transdermal Drug Delivery(TDD) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Transdermal Drug Delivery(TDD) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Transdermal Drug Delivery(TDD), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Transdermal Drug Delivery(TDD), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Transdermal Drug Delivery(TDD), Product Type & Application
 Table 12. Global Key Manufacturers of Transdermal Drug Delivery(TDD), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Transdermal Drug Delivery(TDD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery(TDD) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Transdermal Drug Delivery(TDD) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Transdermal Drug Delivery(TDD) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Transdermal Drug Delivery(TDD) Sales Market Share by Region (2020-2025)
 Table 19. Global Transdermal Drug Delivery(TDD) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Transdermal Drug Delivery(TDD) Sales Market Share by Region (2026-2031)
 Table 21. Global Transdermal Drug Delivery(TDD) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Transdermal Drug Delivery(TDD) Revenue Market Share by Region (2020-2025)
 Table 23. Global Transdermal Drug Delivery(TDD) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Transdermal Drug Delivery(TDD) Revenue Market Share by Region (2026-2031)
 Table 25. North America Transdermal Drug Delivery(TDD) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Transdermal Drug Delivery(TDD) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Transdermal Drug Delivery(TDD) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Transdermal Drug Delivery(TDD) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Transdermal Drug Delivery(TDD) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Transdermal Drug Delivery(TDD) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Transdermal Drug Delivery(TDD) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Transdermal Drug Delivery(TDD) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Transdermal Drug Delivery(TDD) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Transdermal Drug Delivery(TDD) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Transdermal Drug Delivery(TDD) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Transdermal Drug Delivery(TDD) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Transdermal Drug Delivery(TDD) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Transdermal Drug Delivery(TDD) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Transdermal Drug Delivery(TDD) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Transdermal Drug Delivery(TDD) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Transdermal Drug Delivery(TDD) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Transdermal Drug Delivery(TDD) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Transdermal Drug Delivery(TDD) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Transdermal Drug Delivery(TDD) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Transdermal Drug Delivery(TDD) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Transdermal Drug Delivery(TDD) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Transdermal Drug Delivery(TDD) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Transdermal Drug Delivery(TDD) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Transdermal Drug Delivery(TDD) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Transdermal Drug Delivery(TDD) Sales (K Units) by Type (2020-2025)
 Table 51. Global Transdermal Drug Delivery(TDD) Sales (K Units) by Type (2026-2031)
 Table 52. Global Transdermal Drug Delivery(TDD) Sales Market Share by Type (2020-2025)
 Table 53. Global Transdermal Drug Delivery(TDD) Sales Market Share by Type (2026-2031)
 Table 54. Global Transdermal Drug Delivery(TDD) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Transdermal Drug Delivery(TDD) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Transdermal Drug Delivery(TDD) Revenue Market Share by Type (2020-2025)
 Table 57. Global Transdermal Drug Delivery(TDD) Revenue Market Share by Type (2026-2031)
 Table 58. Global Transdermal Drug Delivery(TDD) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Transdermal Drug Delivery(TDD) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Transdermal Drug Delivery(TDD) Sales (K Units) by Application (2020-2025)
 Table 61. Global Transdermal Drug Delivery(TDD) Sales (K Units) by Application (2026-2031)
 Table 62. Global Transdermal Drug Delivery(TDD) Sales Market Share by Application (2020-2025)
 Table 63. Global Transdermal Drug Delivery(TDD) Sales Market Share by Application (2026-2031)
 Table 64. Global Transdermal Drug Delivery(TDD) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Transdermal Drug Delivery(TDD) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Transdermal Drug Delivery(TDD) Revenue Market Share by Application (2020-2025)
 Table 67. Global Transdermal Drug Delivery(TDD) Revenue Market Share by Application (2026-2031)
 Table 68. Global Transdermal Drug Delivery(TDD) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Transdermal Drug Delivery(TDD) Price (US$/Unit) by Application (2026-2031)
 Table 70. Hisamitsu Company Information
 Table 71. Hisamitsu Description and Business Overview
 Table 72. Hisamitsu Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hisamitsu Transdermal Drug Delivery(TDD) Product
 Table 74. Hisamitsu Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan Transdermal Drug Delivery(TDD) Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Transdermal Drug Delivery(TDD) Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Transdermal Drug Delivery(TDD) Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Teve (Actavis) Company Information
 Table 91. Teve (Actavis) Description and Business Overview
 Table 92. Teve (Actavis) Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teve (Actavis) Transdermal Drug Delivery(TDD) Product
 Table 94. Teve (Actavis) Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Transdermal Drug Delivery(TDD) Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. Lohmann Company Information
 Table 101. Lohmann Description and Business Overview
 Table 102. Lohmann Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Lohmann Transdermal Drug Delivery(TDD) Product
 Table 104. Lohmann Recent Developments/Updates
 Table 105. Teikoku Seiyaku Company Information
 Table 106. Teikoku Seiyaku Description and Business Overview
 Table 107. Teikoku Seiyaku Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Teikoku Seiyaku Transdermal Drug Delivery(TDD) Product
 Table 109. Teikoku Seiyaku Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bayer Transdermal Drug Delivery(TDD) Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. Lingrui Company Information
 Table 116. Lingrui Description and Business Overview
 Table 117. Lingrui Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Lingrui Transdermal Drug Delivery(TDD) Product
 Table 119. Lingrui Recent Developments/Updates
 Table 120. Sanofi Company Information
 Table 121. Sanofi Description and Business Overview
 Table 122. Sanofi Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sanofi Transdermal Drug Delivery(TDD) Product
 Table 124. Sanofi Recent Developments/Updates
 Table 125. Zhejiang Ausun Pharmaceutical Company Information
 Table 126. Zhejiang Ausun Pharmaceutical Description and Business Overview
 Table 127. Zhejiang Ausun Pharmaceutical Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Zhejiang Ausun Pharmaceutical Transdermal Drug Delivery(TDD) Product
 Table 129. Zhejiang Ausun Pharmaceutical Recent Developments/Updates
 Table 130. Endo International) Company Information
 Table 131. Endo International) Description and Business Overview
 Table 132. Endo International) Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Endo International) Transdermal Drug Delivery(TDD) Product
 Table 134. Endo International) Recent Developments/Updates
 Table 135. Huarun 999 Company Information
 Table 136. Huarun 999 Description and Business Overview
 Table 137. Huarun 999 Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Huarun 999 Transdermal Drug Delivery(TDD) Product
 Table 139. Huarun 999 Recent Developments/Updates
 Table 140. Haw Par Company Information
 Table 141. Haw Par Description and Business Overview
 Table 142. Haw Par Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Haw Par Transdermal Drug Delivery(TDD) Product
 Table 144. Haw Par Recent Developments/Updates
 Table 145. Nichiban Company Information
 Table 146. Nichiban Description and Business Overview
 Table 147. Nichiban Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Nichiban Transdermal Drug Delivery(TDD) Product
 Table 149. Nichiban Recent Developments/Updates
 Table 150. Mentholatum Company Information
 Table 151. Mentholatum Description and Business Overview
 Table 152. Mentholatum Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Mentholatum Transdermal Drug Delivery(TDD) Product
 Table 154. Mentholatum Recent Developments/Updates
 Table 155. Laboratoires Genevrier Company Information
 Table 156. Laboratoires Genevrier Description and Business Overview
 Table 157. Laboratoires Genevrier Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Laboratoires Genevrier Transdermal Drug Delivery(TDD) Product
 Table 159. Laboratoires Genevrier Recent Developments/Updates
 Table 160. ProStrakan Company Information
 Table 161. ProStrakan Description and Business Overview
 Table 162. ProStrakan Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. ProStrakan Transdermal Drug Delivery(TDD) Product
 Table 164. ProStrakan Recent Developments/Updates
 Table 165. Allergan Company Information
 Table 166. Allergan Description and Business Overview
 Table 167. Allergan Transdermal Drug Delivery(TDD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Allergan Transdermal Drug Delivery(TDD) Product
 Table 169. Allergan Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Transdermal Drug Delivery(TDD) Distributors List
 Table 173. Transdermal Drug Delivery(TDD) Customers List
 Table 174. Transdermal Drug Delivery(TDD) Market Trends
 Table 175. Transdermal Drug Delivery(TDD) Market Drivers
 Table 176. Transdermal Drug Delivery(TDD) Market Challenges
 Table 177. Transdermal Drug Delivery(TDD) Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Transdermal Drug Delivery(TDD)
 Figure 2. Global Transdermal Drug Delivery(TDD) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Transdermal Drug Delivery(TDD) Market Share by Type: 2024 & 2031
 Figure 4. Topical Application Product Picture
 Figure 5. Systemic Administration Product Picture
 Figure 6. Global Transdermal Drug Delivery(TDD) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Transdermal Drug Delivery(TDD) Market Share by Application: 2024 & 2031
 Figure 8. Prescription
 Figure 9. Non-prescription Drugs
 Figure 10. Global Transdermal Drug Delivery(TDD) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Transdermal Drug Delivery(TDD) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Transdermal Drug Delivery(TDD) Sales (2020-2031) & (K Units)
 Figure 13. Global Transdermal Drug Delivery(TDD) Average Price (US$/Unit) & (2020-2031)
 Figure 14. Transdermal Drug Delivery(TDD) Report Years Considered
 Figure 15. Transdermal Drug Delivery(TDD) Sales Share by Manufacturers in 2024
 Figure 16. Global Transdermal Drug Delivery(TDD) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Transdermal Drug Delivery(TDD) Players: Market Share by Revenue in Transdermal Drug Delivery(TDD) in 2024
 Figure 18. Transdermal Drug Delivery(TDD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Transdermal Drug Delivery(TDD) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Transdermal Drug Delivery(TDD) Sales Market Share by Country (2020-2031)
 Figure 21. North America Transdermal Drug Delivery(TDD) Revenue Market Share by Country (2020-2031)
 Figure 22. United States Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Transdermal Drug Delivery(TDD) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Transdermal Drug Delivery(TDD) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Transdermal Drug Delivery(TDD) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Transdermal Drug Delivery(TDD) Revenue Market Share by Region (2020-2031)
 Figure 33. China Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Transdermal Drug Delivery(TDD) Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Transdermal Drug Delivery(TDD) Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Transdermal Drug Delivery(TDD) Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Transdermal Drug Delivery(TDD) Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Transdermal Drug Delivery(TDD) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Transdermal Drug Delivery(TDD) by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Transdermal Drug Delivery(TDD) by Type (2020-2031)
 Figure 52. Global Transdermal Drug Delivery(TDD) Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Transdermal Drug Delivery(TDD) by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Transdermal Drug Delivery(TDD) by Application (2020-2031)
 Figure 55. Global Transdermal Drug Delivery(TDD) Price (US$/Unit) by Application (2020-2031)
 Figure 56. Transdermal Drug Delivery(TDD) Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions